Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 2:33 pm Sale | 2021-12-31 | 13G | Metacrine, Inc. MTCR | venBio Global Strategic Fund L.P. | 0 0.000% | -3,059,123 (Position Closed) | Filing History |
| 2021-02-16 4:53 pm Purchase | 2020-12-31 | 13G | Metacrine, Inc. MTCR | venBio Global Strategic Fund L.P. | 3,059,123 11.800% | 3,059,123 (New Position) | Filing History |
| 2020-07-09 5:28 pm Sale | 2020-07-07 | 13D | Precision BioSciences, Inc. DTIL | venBio Global Strategic Fund L.P. | 84,745 4.900% | -17,370 (-17.01%) | Filing History |
| 2020-07-08 3:54 pm Purchase | 2020-07-06 | 13D | Akero Therapeutics, Inc. AKRO | venBio Global Strategic Fund L.P. | 3,033,552 10.600% | 3,033,552 (New Position) | Filing History |
| 2020-06-24 5:26 pm Sale | 2020-06-22 | 13D | Precision BioSciences, Inc. DTIL | venBio Global Strategic Fund L.P. | 102,115 5.900% | -22,521 (-18.07%) | Filing History |
| 2020-06-08 2:45 pm Sale | 2020-06-03 | 13D | Precision BioSciences, Inc. DTIL | venBio Global Strategic Fund L.P. | 124,636 7.200% | -17,535 (-12.33%) | Filing History |